234 related articles for article (PubMed ID: 15459824)
1. Linkage disequilibrium and haplotype tagging polymorphisms in the Tau H1 haplotype.
Oliveira SA; Scott WK; Zhang F; Stajich JM; Fujiwara K; Hauser M; Scott BL; Pericak-Vance MA; Vance JM; Martin ER
Neurogenetics; 2004 Sep; 5(3):147-55. PubMed ID: 15459824
[TBL] [Abstract][Full Text] [Related]
2. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration.
Pittman AM; Myers AJ; Abou-Sleiman P; Fung HC; Kaleem M; Marlowe L; Duckworth J; Leung D; Williams D; Kilford L; Thomas N; Morris CM; Dickson D; Wood NW; Hardy J; Lees AJ; de Silva R
J Med Genet; 2005 Nov; 42(11):837-46. PubMed ID: 15792962
[TBL] [Abstract][Full Text] [Related]
3. Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy.
Ezquerra M; Pastor P; Gaig C; Vidal-Taboada JM; Cruchaga C; Muñoz E; Martí MJ; Valldeoriola F; Aguilar M; Calopa M; Hernandez-Vara J; Tolosa E
Neurobiol Aging; 2011 Mar; 32(3):547.e11-6. PubMed ID: 19879020
[TBL] [Abstract][Full Text] [Related]
4. 5'-Upstream variants of CRHR1 and MAPT genes associated with age at onset in progressive supranuclear palsy and cortical basal degeneration.
Cruchaga C; Vidal-Taboada JM; Ezquerra M; Lorenzo E; Martinez-Lage P; Blazquez M; Tolosa E; ; Pastor P
Neurobiol Dis; 2009 Feb; 33(2):164-70. PubMed ID: 19022385
[TBL] [Abstract][Full Text] [Related]
5. Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease.
Martin ER; Scott WK; Nance MA; Watts RL; Hubble JP; Koller WC; Lyons K; Pahwa R; Stern MB; Colcher A; Hiner BC; Jankovic J; Ondo WG; Allen FH; Goetz CG; Small GW; Masterman D; Mastaglia F; Laing NG; Stajich JM; Ribble RC; Booze MW; Rogala A; Hauser MA; Zhang F; Gibson RA; Middleton LT; Roses AD; Haines JL; Scott BL; Pericak-Vance MA; Vance JM
JAMA; 2001 Nov; 286(18):2245-50. PubMed ID: 11710889
[TBL] [Abstract][Full Text] [Related]
6. Tau haplotypes regulate transcription and are associated with Parkinson's disease.
Kwok JB; Teber ET; Loy C; Hallupp M; Nicholson G; Mellick GD; Buchanan DD; Silburn PA; Schofield PR
Ann Neurol; 2004 Mar; 55(3):329-34. PubMed ID: 14991810
[TBL] [Abstract][Full Text] [Related]
7. Linkage disequilibrium and association of MAPT H1 in Parkinson disease.
Skipper L; Wilkes K; Toft M; Baker M; Lincoln S; Hulihan M; Ross OA; Hutton M; Aasly J; Farrer M
Am J Hum Genet; 2004 Oct; 75(4):669-77. PubMed ID: 15297935
[TBL] [Abstract][Full Text] [Related]
8. The structure of the tau haplotype in controls and in progressive supranuclear palsy.
Pittman AM; Myers AJ; Duckworth J; Bryden L; Hanson M; Abou-Sleiman P; Wood NW; Hardy J; Lees A; de Silva R
Hum Mol Genet; 2004 Jun; 13(12):1267-74. PubMed ID: 15115761
[TBL] [Abstract][Full Text] [Related]
9. Novel haplotypes in 17q21 are associated with progressive supranuclear palsy.
Pastor P; Ezquerra M; Perez JC; Chakraverty S; Norton J; Racette BA; McKeel D; Perlmutter JS; Tolosa E; Goate AM
Ann Neurol; 2004 Aug; 56(2):249-58. PubMed ID: 15293277
[TBL] [Abstract][Full Text] [Related]
10. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
[TBL] [Abstract][Full Text] [Related]
11. From 1997 to 2007: a decade journey through the H1 haplotype on 17q21 chromosome.
Kalinderi K; Fidani L; Bostantjopoulou S
Parkinsonism Relat Disord; 2009 Jan; 15(1):2-5. PubMed ID: 18424220
[TBL] [Abstract][Full Text] [Related]
12. Further extension of the H1 haplotype associated with progressive supranuclear palsy.
Pastor P; Ezquerra M; Tolosa E; Muñoz E; Martí MJ; Valldeoriola F; Molinuevo JL; Calopa M; Oliva R
Mov Disord; 2002 May; 17(3):550-6. PubMed ID: 12112206
[TBL] [Abstract][Full Text] [Related]
13. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.
Tobin JE; Latourelle JC; Lew MF; Klein C; Suchowersky O; Shill HA; Golbe LI; Mark MH; Growdon JH; Wooten GF; Racette BA; Perlmutter JS; Watts R; Guttman M; Baker KB; Goldwurm S; Pezzoli G; Singer C; Saint-Hilaire MH; Hendricks AE; Williamson S; Nagle MW; Wilk JB; Massood T; Laramie JM; DeStefano AL; Litvan I; Nicholson G; Corbett A; Isaacson S; Burn DJ; Chinnery PF; Pramstaller PP; Sherman S; Al-hinti J; Drasby E; Nance M; Moller AT; Ostergaard K; Roxburgh R; Snow B; Slevin JT; Cambi F; Gusella JF; Myers RH
Neurology; 2008 Jul; 71(1):28-34. PubMed ID: 18509094
[TBL] [Abstract][Full Text] [Related]
14. Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders.
Lai MC; Bechy AL; Denk F; Collins E; Gavriliouk M; Zaugg JB; Ryan BJ; Wade-Martins R; Caffrey TM
Mol Neurodegener; 2017 Oct; 12(1):79. PubMed ID: 29084565
[TBL] [Abstract][Full Text] [Related]
15. The tau gene haplotype h1 confers a susceptibility to Parkinson's disease.
Zhang J; Song Y; Chen H; Fan D
Eur Neurol; 2005; 53(1):15-21. PubMed ID: 15627775
[TBL] [Abstract][Full Text] [Related]
16. GSK3B polymorphisms alter transcription and splicing in Parkinson's disease.
Kwok JB; Hallupp M; Loy CT; Chan DK; Woo J; Mellick GD; Buchanan DD; Silburn PA; Halliday GM; Schofield PR
Ann Neurol; 2005 Dec; 58(6):829-39. PubMed ID: 16315267
[TBL] [Abstract][Full Text] [Related]
17. Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease.
Vandrovcova J; Pittman AM; Malzer E; Abou-Sleiman PM; Lees AJ; Wood NW; de Silva R
Neurobiol Aging; 2009 Sep; 30(9):1477-82. PubMed ID: 18162161
[TBL] [Abstract][Full Text] [Related]
18. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy.
Rademakers R; Melquist S; Cruts M; Theuns J; Del-Favero J; Poorkaj P; Baker M; Sleegers K; Crook R; De Pooter T; Bel Kacem S; Adamson J; Van den Bossche D; Van den Broeck M; Gass J; Corsmit E; De Rijk P; Thomas N; Engelborghs S; Heckman M; Litvan I; Crook J; De Deyn PP; Dickson D; Schellenberg GD; Van Broeckhoven C; Hutton ML
Hum Mol Genet; 2005 Nov; 14(21):3281-92. PubMed ID: 16195395
[TBL] [Abstract][Full Text] [Related]
19. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease.
Zabetian CP; Hutter CM; Factor SA; Nutt JG; Higgins DS; Griffith A; Roberts JW; Leis BC; Kay DM; Yearout D; Montimurro JS; Edwards KL; Samii A; Payami H
Ann Neurol; 2007 Aug; 62(2):137-44. PubMed ID: 17514749
[TBL] [Abstract][Full Text] [Related]
20. Possible association of the tau H1/H1 genotype with primary progressive aphasia.
Sobrido MJ; Abu-Khalil A; Weintraub S; Johnson N; Quinn B; Cummings JL; Mesulam MM; Geschwind DH
Neurology; 2003 Mar; 60(5):862-4. PubMed ID: 12629248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
